Foetal human lung fibroblasts, grown in monolayer, were allowed to incorporate 35SO42-for various periods of time. 35S-labelled macromolecular anionic products were isolated from the medium, a trypsin digest of the cells in monolayer and the cell residue. The various radioactive polysaccharides were identified as heparan sulphate and a galactosaminoglycan population (chondroitin sulphate and dermatan sulphate) by ion-exchange chromatography and by differential degradations with HNO2 and chondroitinase ABC. Most of the heparan sulphate was found in the trypsin digest, whereas the galactosaminoglycan components were largely confined to the medium. Electrophoretic studies on the various 35S-labelled galactosaminoglycans suggested the presence of a separate chondroitin sulphate component (i.e. a glucuronic acid-rich galactosaminoglycan). The 35S-labelled galactosaminoglycans were subjected to periodate oxidation of L-iduronic acid residues followed by scission in alkali. A periodate-resistant polymer fraction was obtained, which could be degraded to disaccharides by chondroitinase AC. However, most of the 35S-labelled galactosaminoglycans were extensively degraded by periodate oxidation-alkaline elimination. The oligosaccharides obtained were essentially resistant to chondroitinase AC, indicating that the iduronic acid-rich galactosaminoglycans (i.e. dermatan sulphate) were composed largely of repeating units containing sulphated or non-sulphated L-iduronic acid residues. The L-iduronic acid residues present in dermatan sulphate derived from the medium and the trypsin digest contained twice as much ester sulphate as did material associated with the cells. The content of D-glucuronic acid was low and similar in all three fractions. The relative distribution of glycosaminoglycans among the various fractions obtained from cultured lungfibroblasts was distinctly different from that ofskin fibroblasts [Malmstrom, Carlstedt, Aberg & Fransson (1975) Biochem. J. 151, 477-489]. Moreover, subtle differences in co-polymeric structure of dermatan sulphate isolated from the two cell types could be detected.
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In recent years the synthesis and secretion of proteoglycans (glycosaminoglycans) by cultured cells of different origin have been studied in a number of laboratories. Established mammalian cell lines of lymphoid, epithelial and fibroblastic origin produce and secrete a variety of glycosaminoglycans into the medium (Saito & Uzman, 1971) . However, fibroblasts generally secrete larger quantities.
Cultured fibroblasts obtained from different tissues seem to retain a specific pattern of secretion. Thus fibroblast-like cells from bovine aorta secrete a mixture of glycosaminoglycans (hyaluronate, heparan sulphate, chondroitin sulphate and dermatan sulphate), the distribution of which closely Vol. 167 resembles that found in the intact tissue (Kresse et al., 1975) . Cultured smooth-muscle cells of primate arteries synthesize principally dermatan sulphate (60-80% of total) and little or no hyaluronic acid (Wight & Ross, 1975) . In contrast, skin fibroblasts of the same species secrete primarily hyaluronic acid (50-60% of total), with lesser amounts of the galactosaminoglycans.
Previous studies in our laboratory have been concerned with the structural features of galactosaminoglycans synthesized by cultured human skin fibroblasts (Malmstrom et al., 1975a) . It was shown that galactosaminoglycans isolated from the medium, a trypsin digest of the cells, and the cell residue differ with respect to the distribution of IdUA-* and GlcUA-containing units. In the present study the structure of galactosaminoglycans produced by fibroblasts from human foetal lung has been investigated. The co-polymeric structure of the galactosaminoglycans synthesized by these cells was distinctly different from that of glycans secreted by skin fibroblasts.
Experimental

Materials
Glycosaminoglycan standards (hyaluronate, pig skin dermatan sulphate, chondroitin 4-sulphate and chondroitin 6-sulphate) and chondroitin sulphate oligosaccharides (hyaluronidase type) were obtained from sources listed previously (Malmstrom et al., 1975a) . Cartilage proteoglycan was a gift from Dr. Sven Inerot of this Department. Twice-crystallized trypsin from bovine pancreas (type III), twice-crystallized papain and bovine serum albumin, were purchased from Sigma Chemical Co., St. Louis, MO, U.S.A. Chondroitinase AC and ABC EC 3.2.1.35) were obtained from Miles Laboratories, Elkhart, IN, U.S.A. Carrier-free Na235SO4 (l24mCi/mmol) was a product of The Radiochemical Centre, Amersham, Bucks., U.K. Materials used for cell cultures (Earle's minimal essential medium, calf serum and antibiotics) were obtained from sources listed previously (Malmstrom et al., 1975a) . Scintillation materials were supplied by Packard A.B., Bandhagen, Sweden. Sephadex and Sepharose gels were purchased from Pharmacia Fine Chemicals, Uppsala, Sweden. Microgranular DEAE-cellulose (Whatman type DE-32) was used for ion-exchange chromatography. Other chemicals were of analytical grade.
Analytical and separatory methods
Uronic acid was determined by an automated version of the carbazole/borate method (Heinegard, 1973) . Protein was determined as described by Lowry et al. (1951) , with bovine serum albumin as standard. Radioactivity was measured with a Packard 2450 liquid-scintillation counter. The scintillation mixtures used were Insta-gel (3 ml of liquidmixed with 2 ml of sample) and Omnifluor in toluene (4 g/litre).
Electrophoresis of 35S-labelled glycosaminoglycans was performed on strips of cellulose acetate in 0.1 M-barium acetate (5 V/cm for 2.5h) as described by Wessler (1968) . The strips were cut, and radioactivity was counted in Omnifluor/toluene (lOml per 2mmx 10mm strip). High-voltage paper electrophoresis of oligosaccharides was performed on * Abbreviations: IdUA, L-iduronic acid; GIcUA, D-glucuronic acid; AUA, 4,5-unsaturated glycuronic acid.
Whatman 3MM paper in 0.1 M-acetic acid adjusted to pH 5.0 by the addition of pyridine (40V/cm; 1 h). Papers were stained with aniline hydrogen phthalate (Partridge, 1949) .
Ion-exchange chromatography was carried out on columns (6 mm x 140 mm) of DE-32 DEAE-cellulose (equilibrated with 0.1 M-sodium acetate, pH 5.0) that were eluted with a linear gradient (0.1-2.5M-sodium acetate, pH 5.0; total elution volume, 100 ml) at a rate of 3 ml/h (Malmstrom et al., 1975a (Fransson, 1974) . The oxidized products were subsequently cleaved by alkaline elmination at pH 12.0 for 30min at room temperature (Fransson & Carlstedt, 1974) . Deaminative cleavage of heparan sulphate was performed by the method of Lagunoff & Warren (1962) (Kraemer, 1971) . As shown by Kraemer (1971) , no irreversible cell damage occurs under these conditions. Moreover, the cells used in the present study excluded Trypan Blue (>95%Y.) and could be satisfactorily re-plated. 1977 The cell residue (containing material not solubilized by trypsin) was suspended in water and extracted with trichloroacetic acid (final concn. 7o%, w/v) for 30min in an ice bath (Kraemer, 1971) . After centrifugation (10000g for 20min) a precipitate and a supernatant solution were obtained. The latter fraction was extracted with diethyl ether. Both fractions were then freeze-dried. The trichloroacetic acid extract (soluble material) has been shown to contain cell-sap heparan sulphate (Kraemer, 1971) . The medium and the trypsin digest (plus 1 mg of carrier dermatan sulphate) were dialysed against 0.1 M-(NH4)2SO4 for 6h, followed by water for 3 days. After addition of carrier to the two cell fractions, all fractions (medium, trypsin digest, soluble and insoluble cellular material) were digested with papain (0.4mg/mI) in 1.OM-NaCl/0.05M-EDTA (disodium salt) /0.01 M-cysteine hydrochloride /0.05 M-sodium phosphate buffer, pH7.0, for 24h at 65°C. The digestion was carried out in the presence of I.OMNaCI to minimize precipitation of 35S-labelled polyanions by basic proteins and peptides (Scott, 1960) . Dialysis against water for 2 days was followed by centrifugation (100OOg for 10min) and freezedrying of the supernatants. The 35S-labelled glycosaminoglycans of the various fractions were finally purified and partially fractionated by ion-exchange chromatography (see above).
The heparan sulphate and the galactosaminoglycan content of the various fractions (or subfractions) were determined as follows. One portion of the 35S-labelled glycosaminoglycans was subjected to digestion with chondroitinase ABC, followed by gel chromatography on Sephadex G-50 (Malmstrom et al., 1975a) . Heparan sulphate emerges with the void volume, whereas the degradation products of the galactosaminoglycans are retarded. Another portion of the material was treated with HNO2, which depolymerizes heparan sulphate (see Lindahl et al., 1973) , but does not attack galactosaminoglycans. In the ensuing gel chromatography, galactosaminoglycans are excluded from the gel, whereas the degradation products of heparan sulphate are included. The same procedure was also used for the isolation of 35S-labelled galactosaminoglycans on a preparative scale (Malmstrom et al., 1 975a) .
Results
Synthesis and secretion of 35S-labelled glycosaminoglycans
The rate of accumulation of 35S-labelled glycosaminoglycans was followed by incorporation of 35SO42-into macromolecular anionic products obtained from the soluble and insoluble cell fraction, the trypsin digest and the medium respectively ( Fig. la) Table 1 . Distribution of35S-labelledglycosaminoglycans after 72h ofincorporation ofradioisotope For details concerning heparan sulphate and total galactosaminoglycans, see the legend to Fig. 1 and the Experimental section. GlcUA-rich galactosaminoglycan corresponds to material released as disaccharide by chondroitinase-AC (n = 1 in Fig. 4 ). Similar results are obtained when material excluded from Sephadex G-50 after periodate oxidationalkaline elimination is considered to be GlcUA-rich (Fig. 5) The 35S-labelled glycosaminoglycans obtained from the various fractions were subjected to differential degradations to determine their heparan sulphate and galactosaminoglycan contents. Fig. l(b) shows that most of the heparan sulphate was found in the trypsin digest (c----c). This material continued to accumulate during the experiment. Heparan sulphate was also secreted into the medium (A----A) . The galactosaminoglycan component (Fig. Ic) The distribution of 35S-labelled glycosaminoglycans after 72 h of incorporation was also examined by ion-exchange chromatography (Fig. 2) . The heparan sulphate and galactosaminoglycan components were poorly resolved, suggesting a relatively high sulphate content in the heparan sulphate molecules. However, the relative distributions of the two components were in agreement with the estimations presented above.
The galactosaminoglycan components of the various fractions were subjected to cellulose acetate electrophoresis in the presence of barium acetate, which separates chondroitin sulphate from dermatan sulphate. As Fig. 3 shows, the 3"S-labelled galactosaminoglycans from the insoluble cell fraction (a) gave a broad peak overlapping both the pig skin dermatan sulphate and the chondroitin sulphate standards. Most of the 35S-labelled galactosaminoglycans of the trypsin digest (b) migrated as chondroitin sulphate, whereas the material from the medium (c) appeared to separate into one dermatan sulphate and one chondroitin sulphate component.
Structure of 35S-labelled galactosaminoglycans
Galactosaminoglycans are usually classified as chondroitin sulphate or dermatan sulphate. Chondroitin sulphate is composed exclusively of GlcUAcontaining repeating units, whereas dermatan sulphate always contains IdUA (Coster et al., 1975) . sulphation of GalNAc moieties to yield the final product (Malmstrom et al., 1975b) . When 35SO42-is incorporated into the molecule, the various repeating units should attain similar specific radioactivities throughout the chain.
To study the occurrence and distribution of the various repeating units (I-111) in 35S-labelled galactosaminoglycans from the various cell-culture fractions, several degradation experiments were performed. Degradations with chondroitinase-AC (which cleaves only GalNAc-GlcUA bonds) followed by gel chromatography gave the results shown in Fig. 4 . The release of radioactivity (representing the disaccharide AUA-GalNAc-SO4, corresponding to repeating unit I) from the galactosaminoglycans of the insoluble cell fraction (a) and the medium (c) was rather small, whereas the glycan of the trypsin digest (b) yielded larger quantities. The yield of oligosaccharides (n = 2-5 in Fig. 4) Selective periodate oxidation of IdUA residues followed by alkaline elimination to achieve fragmentation was also applied to the various 35S-labelled galactosaminoglycans. As Fig. 5 shows, the glycans of the insoluble cell fraction (a) and the medium (c) were degraded to a greater extent than were those of the trypsin digest (b). Thus units containing IdUA (type II) were more prevalent in the glycans of the two former fractions than in the trypsin-released material. Conversely, in the latter material the galactosaminoglycans contained a large proportion of periodate-resistant uronic acid residues (present in repeating units I and III). It should also be noted that the degradation products from the cell material (a) were generally smaller than those derived from the medium (c).
All three glycan fractions gave a distinct voidvolume peak on gel chromatography (Fig. 5) after periodate oxidation-alkaline elimination. This material was further examined by gel chromatography on Sepharose CL6B. As Fig. 6 shows, the respective 35S-labelled galactosaminoglycans were first chromatographed directly ( ). Then material excluded from Sephadex G-50 after periodate oxidationalkaline elimination was rechromatographed on Sepharose CL6B (----). The 35S-labelled galactosaminoglycans isolated after periodate oxidationalkaline elimination of material derived from the trypsin digest (b) and the medium (c) appeared within the same range of molecular sizes as did the starting material. However, the fragments obtained after degradation of the cellular material (----) in (a) were of a smaller size compared with the starting material ( ). [It should also be pointed out that the 35S-labelled galactosaminoglyca-ns ( ) of the cellular fraction were larger than were those of the trypsin digest and the medium.]
The 35S-labelled periodate-resistant galactosaminoglycans derived from the three cell fractions ( Fig. 5 ; void-volume fractions) were subjected to digestion by chondroitinase AC. As Fig. 7 shows, all glycan fractions yielded disaccharide on digestion. where UA is either GIcUA or IdUA-SO4 and R is a C4 fragment derived from an oxidized and degraded IdUA (Fransson & Carlstedt, 1974) . Thus the symbol n denotes the number of hexuronic acid residues in the oligosaccharide (n = 0 corresponds to the compound GaINAc-R). To calculate the radioactivity associated with each oligosaccharide, material was subdivided as indicated by the lower horizontal bars. Fractions were also pooled for further degradations; this is indicated by the upper horizontal bars; the fractions were n>6, n = 3-5, n = 2, n = 1 and n = 0. 35S-labelled galactosaminoglycans were isolated from the insoluble cell fraction (a), the trypsin digest (b) and the medium (c) as described in the Experimental section. One portion of this material was chromatographed directly ( ). Another portion was subjected to periodate oxidation-alkaline elimination followed by gel chromatography as shown in Fig. 5 . Material excluded from this gel (n > 6) was rechromatographed on Sepharose CL6B (----). The column size was 10mmx 1400mm; the eluent was 0.5M-guanidine hydrochloride, pH7.0; the elution rate was 3ml/h. The elution volumes of cartilage proteoglycan (1) and D-glucuronolactone (2) are indicated.
susceptible to this enzyme. The latter fragments should contain IdUA(-SO4)-GalNAc(-SO4) repeating units (type I1I). The above results (Figs. 3-7) suggest that the galactosaminoglycan fractions may be composed of one IdUA-rich and one GlcUA-rich population. The latter population was distinguished by its electrophoretic mobility (Figs. 3b and 3c) The various 35S-labelled degradation products were derived from the galactosaminoglycans of the insoluble cell fraction (a), the trypsin digest (b) and the medium (c). The various 35S-labelled galactosaminoglycans were first degraded by periodate oxidation-alkaline elimination followed by gel chromatography as shown in Fig. 4 . Polymeric and 7). Moreover, it was recovered as a polymeric fraction after periodate oxidation-alkaline elimination (Figs. 5 and 6) . The data of Fig. 4 were used to calculate the amount of GlcUA-rich galactosaminoglycan present in the various fractions. The disaccharides released by chondroitinase AC were assumed to be derived almost entirely from this component. As Table 1 shows, GlcUA-rich variants accounted for a minor proportion (one-third) of the total galactosaminoglycans. However, they were equally distributed between the trypsin digest and the medium. The oligosaccharide fragments n = 1-5 in Fig. 5 obtained after periodate oxidation-alkaline elimination of the various 35S-labelled galactosaminoglycans may contain either IdUA-SO4 or GlcUA, or both. To assess their uronic acid composition, degradations with chondroitinase AC were performed. All the oligosaccharides (n = 1-5) were almost completely resistant to this enzyme, indicating that the uronic acid component was IdUA-SO4.
An attempt was made to estimate the content of various repeating disaccharide units in the IdUA-rich galactosaminoglycan (dermatan sulphate) from the medium, the trypsin digest and the insoluble cell fraction. Since periodate oxidation-alkaline elimination cleaves the chain at the position of IdUA, the results shown in from the data shown in Fig. 4 . The IdUA-SO4 content was calculated as 100-(x+y) (%). As Table 2 Fig. 4) digest and the medium. In previous work the struc-)duced by cells from diftural features of 35S-labelled co-polymeric dermatan 11 attain different specific sulphate produced by skin fibroblasts were also g on the amount of unexamined (Malmstrom et al., 1975a) . Comparisons it at the time of 35SO42-with the results of the present study showed both r, comparisons between the similarities and dissimilarities. In both cell cultures, dermatan sulphate from the trypsin digest and the medium contained fewer IdUA residues than did the cell-associated glycans. Conversely, excreted chains contained larger quantities of IdUA-SO4 residues than did the cellular material. However, dermatan sulphate secreted by skin fibroblasts also contained larger amounts of GlcUA than did cellular glycans. All co-polymeric chains isolated from lung fibroblasts had a similar GlcUA content (Table 2) . Moreover, dermatan sulphate produced by skin fibroblasts and recovered from the trypsin digest contained alternating sequences (-GlcUA-GalNAcIdUA-GalNAc-GlcUA-GalNAc-) (Malmstrom et al., 1975a) . Similar sequences could not be detected in corresponding material from lung fibroblasts.
The composition of the intercellular matrix (material released by trypsin) laid down by cultured fibroblasts from skin and lung was distinctly different. Whereas the matrix surrounding the cells from skin contained both dermatan sulphate and heparan sulphate, that of the lung cells contained large amounts of heparan sulphate, very little dermatan sulphate, and, in addition, a separate GlcUA-rich galactosaminoglycan component. In the previous paper (Malmstrom et al., 1975a) it was proposed that co-polymeric dermatan sulphate chains containing alternating sequences were entrapped in the intercellular matrix owing to interactions with other macromolecules. It has since been demonstrated that co-polymeric chains with these features may interact in vitro to form aggregates (Fransson, 1976) . It is possible that the relatively low content of copolymeric glycans in the matrix produced by lung fibroblasts was because these cells did not synthesize aggregating species. It is not known whether IdUArich and GlcUA-rich chains are part of the same proteoglycan or if separate proteoglycan species exist. Therefore the significance of a relative enrichment of chondroitin sulphate-like chains in the trypsin digest cannot be evaluated. Although heparan sulphate is considered to be a general cellsurface component (Kraemer, 1971) , its biological function remains unknown. Therefore it is difficult to ascertain whether the relatively high content of heparan sulphate in the trypsin digest of lung fibroblasts serves a specific purpose.
The dermatan sulphate produced and secreted by lung fibroblasts was mainly confined to the medium (Table 1 ). The IdUA residues of the secreted material were sulphated to a larger extent (approx. 50 %) than were those of the cell-associated glycans (approx. 25%). This twofold increase in IdUA-SO4 content might be the result of selective secretion of molecules with a certain structure. Alternatively polymer-level modifications of the newly synthesized chains during or after secretion would give the same result. In the previous paper (Malmstrom et al., 1975a) two competing polymer-level reactions were proposed, i.e. IdUA->GlcUA and IdUA --IdUA-SO4. Only the latter reaction should be considered in the present case. Finally, the present studies confirm that fibroblasts from different sources retain a specific pattern of glycosaminoglycan synthesis in cell culture. It is also apparent that even subtle differences in copolymeric structure can be detected.
